Procedure
Rectal cancer surgery
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_3
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
3(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Other(4)
Detailed Status
unknown4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 33 (100.0%)
Trials by Status
unknown4100%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_3
Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer
NCT04103697
unknownphase_3
Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer
NCT04134897
unknownphase_3
Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer
NCT04135313
unknown
Hartmann's Versus Intersphincetric APE: A Prospective, Multicentre Study
NCT02702089
Clinical Trials (4)
Showing 4 of 4 trials
NCT04103697Phase 3
Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer
NCT04134897Phase 3
Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer
NCT04135313Phase 3
Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer
NCT02702089
Hartmann's Versus Intersphincetric APE: A Prospective, Multicentre Study
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4